Literature DB >> 16708135

Pediatric prescribing practices for clonidine and other pharmacologic agents for children with sleep disturbance.

Connie J Schnoes1, Brett R Kuhn, Elizabeth F Workman, Cynthia R Ellis.   

Abstract

The prescription rates of clonidine have risen dramatically and the extent to which these increases can be attributed to treatment of sleep disturbance is unknown. Surveys were mailed to 800 pediatricians across four geographically diverse states to assess prescribing practices specific to sleep disturbance. Ninety-six percent of the respondents treated sleep disturbance. More than one third of the sample reported using clonidine specifically for sleep disturbance including sleep onset, sleep schedule, nighttime awakening, and early morning awakening problems and parasomnias. Clonidine ranked second only to antihistamines as the most commonly used medication for treating sleep disturbance.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16708135     DOI: 10.1177/000992280604500304

Source DB:  PubMed          Journal:  Clin Pediatr (Phila)        ISSN: 0009-9228            Impact factor:   1.168


  4 in total

1.  Toxicity from a clonidine suspension.

Authors:  Mariya Farooqi; Steven Seifert; Susan Kunkel; Mary Johnson; Blaine Benson
Journal:  J Med Toxicol       Date:  2009-09

2.  Poisonings Associated with Intubation: US National Poison Data System Exposures 2000-2013.

Authors:  G A Beauchamp; S L Giffin; B Z Horowitz; A L Laurie; R Fu; R G Hendrickson
Journal:  J Med Toxicol       Date:  2016-06

3.  Hypertensive Crisis in a Pediatric Patient Experiencing Clonidine Withdrawal.

Authors:  Can Cao; Matthew L Lorenz; Phillip Sojka; Allison W Brindle; Lisa Swartz Topor
Journal:  Case Rep Pediatr       Date:  2022-03-22

4.  Effectiveness of Clonidine in Child and Adolescent Sleep Disorders.

Authors:  Young-Jin Jang; Haemi Choi; Tae Sun Han; Dajung Sung; Jae Yeon Woo; Tae-Hyeong Kim; Min-Hyeon Park
Journal:  Psychiatry Investig       Date:  2022-09-22       Impact factor: 3.202

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.